Lantheus Holdings Inc (LNTH)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt LNTH? Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Lantheus Holdings Inc Stock (LNTH) Company Profile

Lantheus Holdings Inc

Healthcare (1074)

978 671-8001

331 TREBLE COVE ROAD, NORTH BILLERICA, MA

Nächster Verdiensttermin

Neueste SEC-Einreichungen

LNTH's Discussions on Twitter

Compare LNTH vs TAK, TEVA, HLN, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LNTH Lantheus Holdings Inc	100.97	6.54B	1.54B	233.56M	348.64M	3.3669
TAK Takeda Pharmaceutical Co Adr	18.45	57.90B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.36	42.89B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.60	43.41B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	75.81	31.00B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	487.61	22.35B	3.17B	1.29B	1.01B	27.09

Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-02-26	Hochstufung	William Blair	Mkt Perform → Outperform
2025-12-12	Hochstufung	Truist	Hold → Buy
2025-10-08	Herabstufung	Goldman	Buy → Neutral
2025-08-12	Herabstufung	Truist	Buy → Hold
2024-12-18	Eingeleitet	Goldman	Buy
2024-09-03	Eingeleitet	Redburn Atlantic	Buy
2024-07-10	Bestätigt	JMP Securities	Mkt Outperform
2023-12-18	Herabstufung	William Blair	Outperform → Mkt Perform
2023-12-04	Eingeleitet	TD Cowen	Outperform
2023-09-29	Eingeleitet	William Blair	Outperform
2023-03-08	Eingeleitet	JMP Securities	Mkt Outperform
2022-11-30	Eingeleitet	SVB Leerink	Outperform
2022-10-13	Eingeleitet	Mizuho	Buy
2022-05-09	Eingeleitet	B. Riley Securities	Buy
2022-04-13	Eingeleitet	Truist	Buy
2021-02-01	Eingeleitet	SVB Leerink	Outperform
2020-06-29	Fortgesetzt	Jefferies	Buy
2019-08-16	Hochstufung	CJS Securities	Market Perform → Market Outperform
2017-11-02	Hochstufung	Wells Fargo	Market Perform → Outperform
2016-11-08	Bestätigt	RBC Capital Mkts	Outperform
2016-09-23	Fortgesetzt	Credit Suisse	Neutral
2016-02-24	Bestätigt	RBC Capital Mkts	Outperform
2015-12-11	Herabstufung	Credit Suisse	Outperform → Neutral
2015-09-30	Herabstufung	Wells Fargo	Outperform → Market Perform
2015-07-20	Eingeleitet	Credit Suisse	Outperform
2015-07-20	Eingeleitet	Jefferies	Buy
2015-07-20	Eingeleitet	RBC Capital Mkts	Outperform
2015-07-20	Eingeleitet	Robert W. Baird	Outperform
2015-07-20	Eingeleitet	Wells Fargo	Outperform

Alle ansehen

Lantheus Holdings Inc Aktie (LNTH) Neueste Nachrichten

Finanzdaten der Lantheus Holdings Inc-Aktie (LNTH)

Lantheus Holdings Inc (LNTH)

Lantheus Holdings Inc Stock (LNTH) Company Profile

Compare LNTH vs TAK, TEVA, HLN, ZTS, UTHR

Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades

Lantheus Holdings Inc Aktie (LNTH) Neueste Nachrichten

Healthcare Equipment and Supplies Stocks Q2 Recap: Benchmarking Lantheus (NASDAQ:LNTH) - Yahoo Finance

Lantheus (LNTH) EPS and Revenue: Profit Per Share Surpasses Its Benchmark in Latest Trading; Session Move - Vinanet

Lantheus Holdings CAO Kimberly Brown Sells 463 Shares for Tax Withholding Purposes - Kalkine Media

Lantheus Holdings, Inc. Stock 12‑Month Price Target Cut to $106.3, Implies 6% Upside - TradingView

Lantheus (LNTH) Q2 2026 Filing Snapshot: The EPS Result Is Above Expectation in the Current Update; Market Follow-Through: The Stock Records a 0.64% Decrease on the DayInvestor Earnings Call - Vinanet

Lantheus Wins FDA Approval for Alzheimer's Tau PET Imaging Agent - finance.biggo.com

B.Riley downgrades Lantheus stock rating on Curium acquisition By Investing.com - Investing.com Australia

B.Riley downgrades Lantheus stock rating on Curium acquisition - Investing.com Nigeria

FDA approves Lantheus tau PET imaging agent for Alzheimer’s disease - DOTmed

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Powerhouse with 6.21% Potential Upside - DirectorsTalk Interviews

Tauklarify PET approval for Lantheus in AD NFT pathology - pharmaphorum

FDA Approves Lantheus Imaging Drug for Alzheimer's Diagnostics - Sahm

Weekly Buzz: LNTH, CBLL Win FDA Nod; AURA Cuts Jobs; TDY Buys VREX; CGEM, DFTX Meet Trial Goals - RTTNews

US FDA approves Lantheus’ brain-imaging agent for Alzheimer’s assessment - KWSN

LNTH Looks 10.1% Overvalued on GF Value™ - GuruFocus

US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment - Reuters

Lantheus Wins FDA Approval for Alzheimer's Tau Imaging Agent Tauklarify - marketscreener.com

Lantheus gains FDA nod for tau PET imaging agent in Alzheimer’s - Seeking Alpha

FDA approves Lantheus’ tau imaging agent for Alzheimer’s disease - Investing.com

FDA approves Lantheus’ tau imaging agent for Alzheimer’s disease By Investing.com - Investing.com Nigeria

Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease - The Manila Times

FDA approves Lantheus brain scan to identify tau in Alzheimer’s - Stock Titan

Farallon group (LNTH) discloses 5.58M-share, 8.6% position in Lantheus - Stock Titan

Lantheus Holdings, Inc. (LNTH) Stock Forecasts - Yahoo Finance

Lantheus Holdings, Inc. (NASDAQ:LNTH) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

(LNTH) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Bowman Consulting Group Ltd. (Nasdaq – BWMN), Bowhead Specialty Holdings Inc. (NYSE – BOW), Lantheus Holdings Inc. (Nasdaq – LNTH), Safety Insuran - WBOC TV

Pacer Advisors Inc. Reduces Stock Holdings in Lantheus Holdings, Inc. $LNTH - MarketBeat

Lantheus Holdings: Why I Am Exiting Before The Merger Closes (NASDAQ:LNTH) - Seeking Alpha

Lantheus Holdings (LNTH): Investor Outlook on Strong Upside Potential and Robust Product Portfolio - DirectorsTalk Interviews

Empowered Funds LLC Takes Position in Lantheus Holdings, Inc. $LNTH - MarketBeat

Lantheus Holdings, Inc. $LNTH is Reinhart Partners LLC.'s 2nd Largest Position - MarketBeat

Assenagon Asset Management S.A. Raises Stock Holdings in Lantheus Holdings, Inc. $LNTH - MarketBeat

Lantheus (LNTH) Stock Shrugs Off Solid Profit As Margin Questions Linger - Sahm

Lantheus (NASDAQ:LNTH) Releases Earnings Results, Beats Expectations By $0.25 EPS - MarketBeat

Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc.LNTH - Business Wire

Form 8K Lantheus Holdings Inc For: 6 August By Investing.com - Investing.com South Africa

LNTH Looks 12.1% Overvalued on GF Value™ - GuruFocus

Lantheus Holdings, Inc. Suspends its Previously Issued Full Year 2026 Financial Guidance - marketscreener.com

Lantheus Holdings Inc earnings beat by $0.26, revenue topped estimates - Investing.com

Lantheus' Q2 Adjusted Earnings Fall, Revenue Rises - marketscreener.com

Lantheus Holdings, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Is Lantheus Holdings Inc (LNTH) Overvalued Despite Q2 Earnings M - GuruFocus

LNTH: Q2 2026 saw revenue growth, strategic acquisitions, and a pending merger with Curium - TradingView

Earnings Flash (LNTH) Lantheus Holdings, Inc. Reports Q2 Revenue $388.2M, vs. FactSet Est of $363.2M - marketscreener.com

Earnings Flash (LNTH) Lantheus Holdings, Inc. Posts Q2 Adjusted EPS $1.55 per Share, vs. FactSet Est of $1.30 - marketscreener.com

Lantheus Q2 revenue rises to $388.2 million - Quiver Quantitative

Lantheus Holdings: Q2 Earnings Snapshot - Barchart.com

Lantheus (NASDAQ:LNTH) Reports Upbeat Q2 CY2026 - Yahoo Finance

Lantheus Reports Second Quarter 2026 Financial Results - marketscreener.com

Press Release: Lantheus Reports Second Quarter 2026 Financial Results - Moomoo

Finanzdaten der Lantheus Holdings Inc-Aktie (LNTH)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie LNTH